Tift Regional Medical Center utilizing new diagnostic lab technology

Bruker Matrix Assisted Laser Desorption Ionization Biotyper CA System meant to provide quicker diagnosis

Getting your Trinity Audio player ready...

From Staff Reports

[email protected]

TIFTON — The Tift Regional Medical Center Laboratory has acquired new diagnostic technology meant to allow for a quicker diagnosis and treatment of patients suffering from bacterial infections such as pneumonia, meningitis, ear infections, wound infections and strep throat.

Dr. Jessica Beier, medical director of the laboratory, said the new Bruker Matrix Assisted Laser Desorption Ionization (MALDI) Biotyper CA System is revolutionizing the way microbial identification is performed.

“To diagnose a suspected bacterial infection, a culture is obtained from a patient and it traditionally requires bacterial growth in the laboratory for 24 hours,” she said. “Then, the bacterial identification of any pathogens takes another 24 to 48 hours before a diagnosis can be reported to a referring physician.

“With this new MALDI Biotyper CA System, a diagnosis and report to the physician can be made during the first day of growth.”

Beier said this is significant because it will allow for faster targeted treatment of patients, possibly reducing length-of-stay in the hospital and improving the utilization of antibiotics.

“Antimicrobial stewardship is a coordinated effort by clinicians to appropriately use antimicrobials, including antibiotics, which improves patient outcomes, reduces microbial resistance and decreases the spread of infections caused by multidrug-resistant organisms,” she said. “Reducing length-of-stay in the hospital means a quicker return to normal activities and greater cost value for the patient, the hospital and health insurance providers.”

The MALDI Biotyper CA System is used in conjunction with other clinical and laboratory findings to aid the diagnosis of what is called “gram-negative” bacterial infections.

“Essentially, this system uses highly-attuned spectrometry and specialized software to identify the molecular fingerprint of an organism,” said Beier. “It can identify 210 species or species groups, covering 280 clinically-relevant bacteria and yeast species, representing more than 98 percent of the typical bacterial identification in a clinical laboratory.”

In addition to being faster than traditional methods, Beier said the MALDI Biotyper CA System is more cost effective, easier to use, and utilizes less space in the laboratory.

“It will really help improve our workflow,” she stated. “But, most importantly, it will enhance the level of care provided to our patients.”

Attention home delivery customers:
Starting March 4, your paper will be delivered by the post office.

We appreciate your patience.
Questions? Call 229-888-9300.

Sovrn Pixel